Please Wait
Applying Filters...
menu
    • menu
    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    An Enquiry

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    An Enquiry

    Menu

    Zonegran, Zonisamide

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 284Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Alkem’s Generics Zonisamide Receives Tentative Approval in US
    Alkem’s Generics Zonisamide Receives Tentative Approval in US

    24 Mar 2026

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=220352

    FDA
    24 Mar 2026
    Share Share
    FDA Confirms Para IV Patent Litigation for Zonisade Suspension
    FDA Confirms Para IV Patent Litigation for Zonisade Suspension

    21 Mar 2025

    // FDA

    https://www.pharmacompass.com/pdf/news/fda-confirms-para-iv-patent-litigation-for-zonisade-suspension-91339.pdf

    FDA
    21 Mar 2025
    Share Share
    Manufacturing and Marketing Approval for Three Ingredients and Eight Items
    Manufacturing and Marketing Approval for Three Ingredients and Eight Items

    15 Feb 2024

    // PRESS RELEASE

    https://www.towayakuhin.co.jp/english/assets/info/pdf/release240215.pdf

    PRESS RELEASE
    15 Feb 2024
    Share Share
    Mylan Pharmaceuticals' Zonisamide Mylan (Zonisamide) Receives Approval in Europe
    Mylan Pharmaceuticals' Zonisamide Mylan (Zonisamide) Receives Approval in Europe

    08 Jun 2023

    // EMA

    https://www.ema.europa.eu/en/medicines/human/EPAR/zonisamide-mylan

    EMA
    08 Jun 2023
    Share Share
    Amdipharm's Zonegran Receives Approval in Europe
    Amdipharm's Zonegran Receives Approval in Europe

    09 Dec 2022

    // EMA

    https://www.ema.europa.eu/en/documents/overview/zonegran-epar-summary-public_en.pdf

    EMA
    09 Dec 2022
    Share Share
    Eton Pharma Announces FDA Approval of ZONISADE (Zonisamide Oral Suspension)
    Eton Pharma Announces FDA Approval of ZONISADE (Zonisamide Oral Suspension)

    18 Jul 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/07/18/2480941/0/en/Eton-Pharmaceuticals-Announces-FDA-Approval-of-ZONISADE-Zonisamide-Oral-Suspension.html

    GLOBENEWSWIRE
    18 Jul 2022
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.